Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00419536
Status:
TERMINATED
Last Update Posted:
2010-04-08
First Post:
2007-01-05
Brief Title:
Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CLBH589A2105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
External Affairs
Old Organization:
Novartis Pharmaceuticals